Literature DB >> 18157379

[Hormone therapy in menopause: when not to use].

Poli Mara Spritzer1, Maria Celeste Osório Wender.   

Abstract

Menopause is defined as the permanent cessation of menses, as a result of the loss of ovarian follicular function or of surgical removal of ovaries. The mean age for occurrence of natural menopause is around 50 years. Estrogen deficiency has been associated with vasomotor symptoms, urogenital atrophy, and cognitive impairment, as well as increased risk of chronic degenerative diseases such as osteoporosis and Alzheimer's disease. Estrogen therapy remains the most effective treatment for the management of vasomotor symptoms and urogenital atrophy. Progesterone or progestins should be added to estrogen treatment in women with uterus, in order to antagonize the estrogen-induced endometrial proliferation. In turn, in specific clinical conditions hormone therapy is not recommended. In the present article, the authors critically focus these clinical conditions in which hormone therapy should not be used.

Entities:  

Mesh:

Year:  2007        PMID: 18157379     DOI: 10.1590/s0004-27302007000700006

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  1 in total

1.  Developmental toxicity and brain aromatase induction by high genistein concentrations in zebrafish embryos.

Authors:  Dong-Jae Kim; Seung-Hyeok Seok; Min-Won Baek; Hui-Young Lee; Yi-Rang Na; Sung-Hoon Park; Hyun-Kyoung Lee; Noton Kumar Dutta; Koichi Kawakami; Jae-Hak Park
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.